Strata Critical Medical (SRTA) Gross Profit (2021 - 2025)
Historic Gross Profit for Strata Critical Medical (SRTA) over the last 5 years, with Q3 2025 value amounting to $11.6 million.
- Strata Critical Medical's Gross Profit rose 5468.83% to $11.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $75.7 million, marking a year-over-year increase of 7593.87%. This contributed to the annual value of $58.9 million for FY2024, which is 3987.7% up from last year.
- According to the latest figures from Q3 2025, Strata Critical Medical's Gross Profit is $11.6 million, which was up 5468.83% from $17.7 million recorded in Q2 2025.
- Over the past 5 years, Strata Critical Medical's Gross Profit peaked at $34.3 million during Q4 2024, and registered a low of $1.5 million during Q1 2021.
- Its 5-year average for Gross Profit is $9.8 million, with a median of $9.0 million in 2023.
- Over the last 5 years, Strata Critical Medical's Gross Profit had its largest YoY gain of 28117.65% in 2024, and its largest YoY loss of 5180.69% in 2024.
- Strata Critical Medical's Gross Profit (Quarter) stood at $3.9 million in 2021, then grew by 26.24% to $5.0 million in 2022, then skyrocketed by 81.11% to $9.0 million in 2023, then skyrocketed by 281.18% to $34.3 million in 2024, then crashed by 66.18% to $11.6 million in 2025.
- Its Gross Profit was $11.6 million in Q3 2025, compared to $17.7 million in Q2 2025 and $12.0 million in Q1 2025.